| Type | Title | Date Released | |
|---|---|---|---|
10-Q | Form 10-Q | ||
8-K | Apyx Medical Reports Third Quarter 2026 Financial Results and Reaffirms Full Year Guidance | ||
SCHEDULE 13G | Philotimo Fund, LP (Filed by) | ||
8-K | Apyx Medical Announces New Clinical Study Demonstrating Renuvion’s Impact on Skin Quality | ||
8-K | Apyx Medical Corporation Announces Results of 2026 Annual Meeting of Stockholders | ||
10-Q | Form 10-Q | ||
8-K | Apyx Medical Corporation Reports Second Quarter 2026 Financial Results | ||
8-K | Apyx Medical Corporation Reconstitutes Board of Directors Committees | ||
SCHEDULE 13G/A | ROYCE & ASSOCIATES LP (Filed by) | ||
4 | Waldman Lawrence (Reporting) | ||
DEF 14A | Form DEF 14A | ||
4 | Roman Shawn David (Reporting) |
